Neurophysiological models for new treatment development in schizophrenia: Early sensory approaches

Annals of the New York Academy of Sciences

Volumn 1344, Issue 1, 2015, Pages 92-104

  Javitt, Daniel C ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Auditory; Event related potentials; Glutamate; Mismatch negativity; N methyl d aspartate receptor; Visual

Indexed keywords

GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ARTICLE; AUDITORY CORTEX; COGNITION; CONTINUOUS PERFORMANCE TEST; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; EVOKED VISUAL RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MAGNETOENCEPHALOGRAPHY; MISMATCH NEGATIVITY; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; SCHIZOPHRENIA; TEMPORAL CORTEX; VISION; WORKING MEMORY; ANIMAL; AUDITORY STIMULATION; BIOLOGICAL MODEL; COGNITION DISORDERS; DISEASE MODEL; EVOKED RESPONSE; MEMORY; METABOLISM; PATHOPHYSIOLOGY; PHOTOSTIMULATION;

ANIMALIA;

ACOUSTIC STIMULATION; ANIMALS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; HUMANS; MEMORY; MODELS, NEUROLOGICAL; PHOTIC STIMULATION; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 84928269490     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.12689     Document Type: Article

References (77)

1. Howes, O.D. & S. Kapur . 2009. The dopamine hypothesis of schizophrenia: version III-the final common pathway. Schizophr. Bull. 35: 549-562.
2. Morris, S.E. & B. N. Cuthbert . 2012. Research domain criteria: cognitive systems, neural circuits, and dimensions of behavior. Dialogues Clin. Neurosci. 14: 29-37.
3. Javitt, D.C. et al. 2008. Neurophysiological biomarkers for drug development in schizophrenia. Nat. Rev. 7: 68-83.
4. Javitt, D.C. et al. 2011. Translating glutamate: from pathophysiology to treatment. Sci. Transl. Med. 3: 102mr102.
5. Javitt, D.C. & S.R. Zukin . 1990. The role of excitatory amino acids in neuropsychiatric illness. J. Neuropsychiatry Clin. Neurosci. 2: 44-52.
6. Javitt, D.C. 2009. When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. Ann. Rev. Clin. Psychol. 5: 249-275.
7. Javitt, D.C. & S.R. Zukin . 1991. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148: 1301-1308.
8. Leitman, D.I. et al. 2010. Sensory deficits and distributed hierarchical dysfunction in schizophrenia. Am. J. Psychiatry 167: 818-827.
9. Umbricht, D.S. et al. 2006. Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia. Biol. Psychiatry 59: 762-772.
10. Light, G.A. et al. 2012. Characterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophrenia. PLoS One 7: e39434.
11. Schechter, I. et al. 2005. Impairments in generation of early-stage transient visual evoked potentials to magno- and parvocellular-selective stimuli in schizophrenia. Clin. Neurophysiol. 116: 2204-2215.
12. Martinez, A. et al. 2008. Magnocellular pathway impairment in schizophrenia: evidence from functional magnetic resonance imaging. J. Neurosci. 28: 7492-7500.
13. Dias, E.C. et al. 2013. Abnormal task modulation of oscillatory neural activity in schizophrenia. Front Psychol. 4: 540.
14. Javitt, D.C. et al. 1993. Impairment of early cortical processing in schizophrenia: an event-related potential confirmation study. Biol. Psychiatry 33: 513-519.
15. Friedman, T. et al. 2012. Differential relationships of mismatch negativity and visual p1 deficits to premorbid characteristics and functional outcome in schizophrenia. Biol. Psychiatry 71: 521-529.
16. Thönnessen, H. et al. 2008. Optimized mismatch negativity paradigm reflects deficits in schizophrenia patients. A combined EEG and MEG study. Biol. Psychol. 77: 205-216.
17. Todd, J. et al. 2008. Deviant matters: duration, frequency, and intensity deviants reveal different patterns of mismatch negativity reduction in early and late schizophrenia. Biol. Psychiatry 63: 58-64.
18. Salisbury, D.F. et al. 2007. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch. Gen. Psychiatry 64: 521-529.
19. Bodatsch, M. et al. 2011. Prediction of psychosis by mismatch negativity. Biol. Psychiatry 69: 959-966.
20. Perez, V.B. et al. 2014. Automatic auditory processing deficits in schizophrenia and clinical high-risk patients: forecasting psychosis risk with mismatch negativity. Biol. Psychiatry 75: 459-469.
21. Carrión, R.E. et al. 2015. Contributions of early cortical processing and reading ability to functional status in individuals at clinical high risk for psychosis. Schiz. Res. DOI: http://dx.doi.org/10.1016/j.schres.2015.01.030.
22. Javitt, D.C. 2000. Intracortical mechanisms of mismatch negativity dysfunction in schizophrenia. Audiol. Neurootol. 5: 207-215.
23. Kreitschmann-Andermahr, I. et al. 2001. Effect of ketamine on the neuromagnetic mismatch field in healthy humans. Brain Res. Cogn. Brain Res. 12: 109-116.
24. Mathiak, K. et al. 2002. Mismatch responses to randomized gradient switching noise as reflected by fMRI and whole-head magnetoencephalography. Hum. Brain Mapp. 16: 190-195.
25. Pekkonen, E. et al. 2002. Impaired temporal lobe processing of preattentive auditory discrimination in schizophrenia. Schizophr. Bull. 28: 467-474.
26. Shin, K.S. et al. 2012. Aberrant auditory processing in schizophrenia and in subjects at ultra-high-risk for psychosis. Schizophr. Bull. 38: 1258-1267.
27. Wible, C.G. et al. 2001. A functional magnetic resonance imaging study of auditory mismatch in schizophrenia. Am. J. Psychiatry 158: 938-943.
28. Kircher, T.T. et al. 2004. Mismatch negativity responses in schizophrenia: a combined fMRI and whole-head MEG study. Am. J. Psychiatry 161: 294-304.
29. Javitt, D.C. et al. 1992. Demonstration of mismatch negativity in the monkey. Electroencephalogr. Clin. Neurophysiol. 83: 87-90.
30. Javitt, D.C. et al. 1996. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 93: 11962-11967.
31. Javitt, D.C. & R. Freedman . 2015. Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. Am. J. Psychiatry 172: 17-31.
32. Gil-da-Costa, R. et al. 2013. Nonhuman primate model of schizophrenia using a noninvasive EEG method. Proc. Natl. Acad. Sci. U.S.A. 110: 15425-15430.
33. Umbricht, D. et al. 2000. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch. Gen. Psychiatry 57: 1139-1147.
34. Heekeren, K. et al. 2008. Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis. Psychopharmacology (Berl) 199: 77-88.
35. Gunduz-Bruce, H. et al. 2012. Glutamatergic modulation of auditory information processing in the human brain. Biol. Psychiatry 71: 969-977.
36. Umbricht, D. et al. 2003. Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia. Neuropsychopharmacology 28: 170-181.
37. Kasai, K. et al. 2002. Do high or low doses of anxiolytics and hypnotics affect mismatch negativity in schizophrenic subjects? An EEG and MEG study. Clin. Neurophysiol. 113: 141-150.
38. Leung, S. et al. 2007. Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects. Psychopharmacology (Berl) 194: 443-451.
39. Korostenskaja, M., D. Kicic & S. Kahkonen . 2008. The effect of methylphenidate on auditory information processing in healthy volunteers: a combined EEG/MEG study. Psychopharmacology (Berl) 197: 475-486.
40. Umbricht, D. et al. 2002. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol. Psychiatry 51: 400-406.
41. Korostenskaja, M. et al. 2007. Effects of NMDA receptor antagonist memantine on mismatch negativity. Brain Res. Bull. 72: 275-283.
42. Kantrowitz, J.T. & D.C. Javitt . 2014. Amelioration of neurophysiological deficits in schizophrenia by high-dose D-serine: relevance for clinical treatment development. Biol. Psychiatry 75: 11S.
43. Lavoie, S. et al. 2008. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology 33: 2187-2199.
44. Preskorn, S. H. et al. 2014. Normalizing effects of EVP-6124, an alpha-7 nicotinic partial agonist, on event-related potentials and cognition: a proof of concept, randomized trial in patients with schizophrenia. J. Psychiatr. Pract. 20: 12-24.
45. Javitt, D.C. & R.A. Sweet . Auditory dysfunction in schizophrenia: integrating clinical and basic features. Nat. Rev. Neurosci. In review.
46. Roth, W. & E. Cannon . 1972. Some features of the auditory evoked response in schizophrenics. Arch. Gen. Psychiatry 27: 466-471.
47. Ford, J.M. et al. 2001. N1 and P300 abnormalities in patients with schizophrenia, epilepsy, and epilepsy with schizophrenialike features. Biol. Psychiatry 49: 848-860.
48. Shelley, A.M., G. Silipo & D.C. Javitt . 1999. Diminished responsiveness of ERPs in schizophrenic subjects to changes in auditory stimulation parameters: implications for theories of cortical dysfunction. Schizophr. Res. 37: 65-79.
49. Arezzo, J., A. Pickoff & H. G. Vaughan, Jr. 1975. The sources and intracerebral distribution of auditory evoked potentials in the alert rhesus monkey. Brain Res. 90: 57-73.
50. Javitt, D.C. et al. 2000. Schizophrenia-like deficits in auditory P1 and N1 refractoriness induced by the psychomimetic agent phencyclidine (PCP). Clin. Neurophysiol. 111: 833-836.
51. Dias, E.C. et al. 2011. Early sensory contributions to contextual encoding deficits in schizophrenia. Arch. Gen. Psychiatry 68: 654-664.
52. Doniger, G.M. et al. 2002. Impaired visual object recognition and dorsal/ventral stream interaction in schizophrenia. Arch. Gen. Psychiatry 59: 1011-1020.
53. Sehatpour, P. et al. 2010. Impaired visual object processing across an occipital-frontal-hippocampal brain network in schizophrenia: an integrated neuroimaging study. Arch. Gen. Psychiatry 67: 772-782.
54. Butler, P.D. et al. 2009. Sensory contributions to impaired emotion processing in schizophrenia. Schizophr. Bull. 35: 1095-1107.
55. Green, M.F., K.H. Nuechterlein & J. Mintz . 1994. Backward masking in schizophrenia and mania. I. Specifying a mechanism. Arch. Gen. Psychiatry 51: 939-944.
56. Chen, C.M. et al. 2007. Functional anatomy and interaction of fast and slow visual pathways in macaque monkeys. Cereb. Cortex 17: 1561-1569.
57. Martinez, A. et al. 2012. Impaired magnocellular/dorsal stream activation predicts impaired reading ability in schizophrenia. NeuroImage Clin. 2: 8-16.
58. Martinez, A. et al. 2012. Consequences of magnocellular dysfunction on processing attended information in schizophrenia. Cereb. Cortex 22: 1282-1293.
59. Butler, P.D. et al. 2007. Subcortical visual dysfunction in schizophrenia drives secondary cortical impairments. Brain 130: 417-430.
60. Sehatpour, P. et al. 2006. Spatiotemporal dynamics of human object recognition processing: an integrated high-density electrical mapping and functional imaging study of "closure" processes. Neuroimage 29: 605-618.
61. Revheim, N. et al. 2014. Reading deficits in schizophrenia and individuals at high clinical risk: relationship to sensory function, course of illness, and psychosocial outcome. Am. J. Psychiatry 171: 949-959.
62. Javitt, D.C. et al. 1995. Cognitive event-related potentials in human and non-human primates: implications for the PCP/NMDA model of schizophrenia. Electroencephalogr. Clin. Neurophysiol. Suppl. 44: 161-175.
63. Di Russo, F. et al. 2002. Cortical sources of the early components of the visual evoked potential. Hum. Brain Mapp. 15: 95-111.
64. Chen, Y. 2011. Abnormal visual motion processing in schizophrenia: a review of research progress. Schizophr. Bull. 37: 709-715.
65. Kim, D. et al. 2005. Dysfunction of early-stage visual processing in schizophrenia: harmonic analysis. Schizophr. Res. 76: 55-65.
66. Purpura, K., E. Kaplan & R.M. Shapley . 1988. Background light and the contrast gain of primate P and M retinal ganglion cells. Proc. Natl. Acad. Sci. U.S.A. 85: 4534-4537.
67. Fox, K. & N. Daw . 1992. A model for the action of NMDA conductances in the visual cortex. Neural Comput. 4: 59-83.
68. Kwon, Y.H. et al. 1992. Effect of stimulus contrast and size on NMDA receptor activity in cat lateral geniculate nucleus. J. Neurophysiol. 68: 182-196.
69. Butler, P.D. et al. 2005. Early-stage visual processing and cortical amplification deficits in schizophrenia. Arch. Gen. Psychiatry 62: 495-504.
70. Schroeder, C.E. et al. 1997. N-methyl-D-aspartate enhancement of phasic responses in primate neocortex. Exp. Brain Res. 114: 271-278.
71. Javitt, D.C., A. Shelley & W. Ritter . 2000. Associated deficits in mismatch negativity generation and tone matching in schizophrenia. Clin. Neurophysiol. 111: 1733-1737.
72. Bickel, S. et al. 2012. Expectancy-related modulations of neural oscillations in continuous performance tasks. Neuroimage 62: 1867-1876.
73. Lakatos, P. et al. 2013. The spectrotemporal filter mechanism of auditory selective attention. Neuron 77: 750-761.
74. Lakatos, P. et al. 2009. The leading sense: supramodal control of neurophysiological context by attention. Neuron 64: 419-430.
75. Lakatos, P. et al. 2013. Predictive suppression of cortical excitability and its deficit in schizophrenia. J. Neurosci. 33: 11692-11702.
76. Light, G.A. & N.R. Swerdlow . 2015. Future clinical uses of neurophysiological biomarkers to predict and monitor treatment response for schizophrenia. Ann. N.Y. Acad. Sci. 1344: 105-119.
77. Featherstone, R.E. et al. 2015. EEG biomarkers of target engagement, therapeutic effect, and disease process. Ann. N.Y. Acad. Sci. 1344: 12-26.